Rocky Mountain Cancer is a clinical research site located in Aurora, Colorado, United States 80012.
Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.
Rocky Mountain Cancer has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Pancreatic Cancer, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma.
Sponsors: Revolution Medicines, Inc..
Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Rocky Mountain Cancer has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Rocky Mountain Cancer has 1 clinical trials on record, with 1 currently active. Their work covers Pancreatic Cancer, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma.
Rocky Mountain Cancer has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.